SLC25A15P5

Across TCGA pan-cancer cohorts, SLC25A15P5 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SLC25A15P5’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SLC25A15P5 RNA is repressed in tumor relative to normal tissue. In most cancer types SLC25A15P5 is over-expressed in tumor, although a few such as KIRC and BRCA show the opposite, repressed pattern.

KIRC, BRCA, and LUSC are the cancer types where SLC25A15P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC25A15P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	IV	−0.450	<.001	12	view →
BRCA	All	III,IV	−0.568	.006	2	view →
LUSC	Male	III,IV	−0.550	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SLC25A15P5–KIRC

Open the KIRC breakdown →